Metabolic and renal effects of laevo-carnitine and propionyl-carnitine in rats with subtotal nephrectomy

Pharmacological Research

Volumn 34, Issue 3-4, 1996, Pages 161-165

  Palomba, D ^a   Pes, G M ^a   Demontis, M P ^a   Varoni, M V ^a   Deiana, L ^a   Anania, Vittorio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Carnitine; Cholesterol; Renal failure; Triglycerides

Indexed keywords

CARNITINE; CREATININE; PROPIONYLCARNITINE; SODIUM ION; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEART RATE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FAILURE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030239442     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0083     Document Type: Article

References (17)

1. 1. Bremer J. Carnitine: metabolism and functions. Physiol Rev 1983; 63: 1420-80.
2. 2. Maccari F, Arseni A, Chiodi P, Ramacci MT, Angelucci L, Hulsmann WC. L-carnitine effect on plasma lipoproteins of hyperlipidemic fat-loaded rats. Lipids 1987; 22: 1005-8.
3. 3. Fiorini F, Patrone E, Castellucci A. Carnitine metabolism in chronic kidney failure. Clin Ter 1992; 140: 31-4.
4. 4. Bomher T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent dialysis for renal failure. Lancet 1978; 7: 126-30.
5. 5. Cevese A, Schena F, Cerutti G. Short-term hemodynamic effects of intravenous propyonil-L-carnitine in anesthetized dogs. Cardiovasc Drugs Ther 1991; 5(Suppl.): 45-56.
6. 6. Olson JL, Hosteller TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982; 22: 112-26.
7. 7. Ferrari R, Ceconi C, Curello S, Pasini E, Visioli O. Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage. Mol Cell Biochem 1989; 88: 161-8.
8. 8. Nilsson J, Mannickarottu V, Edelstein C, Scanu AM. An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultracentrifugation. Analyt Biochem 1981; 110: 342-8.
9. 9. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35: 1093-6.
10. 10. Neely Jr, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974; 36: 413-59.
11. 11. Shi-Hua Chen, Lincoln SD. Increased serum carnitine concentration in renal insufficiency. Clin Chem 1977; 23: 278-80.
12. 12. Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook DW, Kopple LD. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 1990; 38: 904-11.
13. 13. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 1990; 38: 904-11.
14. 14. Clarke PRH, Bieber LL. Effect of micelles on the kinetics of purified beef heart mitochondrial carnitine palmitoyl-transferase. J Biol Chem 1981; 256: 9869-73.
15. 15. Liedtke AJ, DeMaison L, Nellis SH. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988; 255: 169-76.
16. 16. Nestel PJ, Fidge NH, Tan MH. Increased lipoproteinremnant formation in chronic renal failure. N Engl J Med 1982; 307: 329-33.
17. 17. Murakami R, Momota T, Yoshiya K, Yoshikawa N, Nakamura H, Honda M, Ito H. Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialisys. J Pediatr Gastroenterol Nutr 1990; 11: 371-4.